Question · asked by 1 review

Zuclopenthixol dihydrochloride vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE: Leaving the study early

Population
schizophrenia
Intervention
Zuclopenthixol dihydrochloride
Comparison
OTHER ANTIPSYCHOTIC: f. PERPHENAZINE
Outcome
Leaving the study early

It is very uncertain whether zuclopenthixol dihydrochloride changes leaving the study early (any reason, short and medium term) compared with perphenazine (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Zuclopenthixol dihydrochloride vs perphenazine
Leaving the study early (any reason, short and medium term) · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride changes leaving the study early (any reason, short and medium term) compared with perphenazine (very low certainty).
Zuclopenthixol dihydrochloride for schizophrenia (2017) · Cochrane Headline outcomes only
RR 0.63 [0.27, 1.47]2 studies · 104 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Zuclopenthixol dihydrochloride for schizophrenia
2017 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.